Chemoinformaics analysis of 7-(2,3-Dihydroxy-3-methylbutoxy)-4-methoxyfuro[2,3-b]quinoline
| Molecular Weight | 317.341 | nRot | 5 |
| Heavy Atom Molecular Weight | 298.189 | nRig | 15 |
| Exact Molecular Weight | 317.126 | nRing | 3 |
| Solubility: LogS | -3.297 | nHRing | 2 |
| Solubility: LogP | 2.643 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 1 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 13 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 15 |
| nHA | 6 | APOL | 46.1691 |
| nHD | 2 | BPOL | 25.4089 |
| QED | 0.752 |
| Synth | 3.211 |
| Natural Product Likeliness | 1.135 |
| NR-PPAR-gamma | 0.774 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.01 |
| HIA | 0.024 |
| CACO-2 | -4.919 |
| MDCK | 0.0000192 |
| BBB | 0.63 |
| PPB | 0.933737 |
| VDSS | 0.489 |
| FU | 0.0482132 |
| CYP1A2-inh | 0.903 |
| CYP1A2-sub | 0.659 |
| CYP2c19-inh | 0.139 |
| CYP2c19-sub | 0.538 |
| CYP2c9-inh | 0.399 |
| CYP2c9-sub | 0.747 |
| CYP2d6-inh | 0.432 |
| CYP2d6-sub | 0.773 |
| CYP3a4-inh | 0.122 |
| CYP3a4-sub | 0.339 |
| CL | 11.494 |
| T12 | 0.287 |
| hERG | 0.079 |
| Ames | 0.149 |
| ROA | 0.093 |
| SkinSen | 0.114 |
| Carcinogencity | 0.783 |
| EI | 0.015 |
| Respiratory | 0.772 |
| NR-Aromatase | 0.5 |
| Antiviral | Yes |
| Prediction | 0.814435 |